Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07121751Phase 4Not Yet Recruiting

Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF)

Role: collaborator

NCT06875752Phase 4Recruiting

Is There a Need for Luteal Support in Modified Natural Cycle Frozen Embryo Transfer Cycles

Role: collaborator

NCT06781164Not ApplicableCompleted

Examination of the Applicability and Performance of Otolaryngology Telemedicine, Telediagnostics in Establishing the Diagnosis and Therapy of Otolaryngology Diseases

Role: collaborator

NCT03049995Unknown

Stress Echo 2020 - The International Stress Echo Study

Role: collaborator

All 4 trials loaded